With this deal, LGM Pharma will expand its Contract Development and Manufacturing Organisation capabilities. This move will also enable its customers to accelerate and optimise the new product pathway from early development through commercialisation.
Under the contract, LGM Pharma will receive experienced employees and fully equipped facilities, as well as expertise in pharmaceutical finished product development and manufacturing.
Florida/USA – LGM Pharma has recently announced that it has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma. The combination brings together LGM Pharma’s global leadership in Active Pharmaceutical Ingredient (API) sourcing, distribution and supply chain management with Nexgen Pharma’s comprehensive drug product contract development and manufacturing (CDMO) services. The combined firm, which will continue to be known as LGM Pharma, has all the capabilities needed to help pharmaceutical and biotechnology customers accelerate and optimise the new product pathway, from early R&D and clinical development through manufacturing, regulatory submission, commercialisation and distribution.
LGM Pharma is a recognised global leader in sourcing and distribution of quality APIs, providing clients with streamlined API supply chain management from R&D through commercialisation. LGM Pharma accesses APIs from a global network of more than 250 fully accredited CGMP manufacturing partners, optimising API sourcing for its hundreds of customers worldwide while also providing unparalleled supply chain security and risk mitigation strategies. LGM Pharma leverages its extensive network of API suppliers to support hundreds of clients and projects in the 505(b)(2), Anda, OTC, and compounding pharmacy markets.
Nexgen Pharma’s capabilities are highly complementary to LGM Pharma’s core business and expertise. Specialising in the development and manufacture of solid dose, powder, semi-solid, and liquid drugs, Nexgen has been manufacturing healthcare products with a rigorous commitment to quality and customer satisfaction for decades. It provides customers a comprehensive one-stop manufacturing solution that includes formulation development; analytical method development and process validation; Anda / NDA regulatory support and submission; stability studies; raw material and finished product testing; and packaging and distribution.
Published: Jul 30, 2020